News

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced a new supply agreement with Israel for 2022. Under the terms of this…
Read More...

Janux Therapeutics announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford…
Read More...

Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome. As Adare has committed to growing its Pharma Solutions and…
Read More...

Syneos Health the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform for patient-centered drug development, announced a strategic…
Read More...

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership with Rocket Pharmaceuticals, a…
Read More...

Today, the European Commission (EC) approved Sarclisa (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with relapsed multiple…
Read More...

Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, announced a strategic partnership to accelerate the…
Read More...

The U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered…
Read More...

GSK and Vir continue discussions with global regulators to make VIR-7831 available to patients with COVID-19. GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the…
Read More...

Thermo Fisher Scientific Inc. and PPD, Inc. announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share…
Read More...

Alligator Bioscience announced that it has entered into a joint research collaboration with MacroGenics, Inc. a biopharmaceutical company focused on developing and commercializing…
Read More...

INOVIO a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, and cancer, announced the…
Read More...

Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and market cilastatin, a…
Read More...

SciNeuro Pharmaceuticals, an innovative biopharmaceutical company focused on delivering transformative therapies to patients with neurological diseases, has entered into an exclusive…
Read More...

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a partnership with Pure…
Read More...

AbCellera and Empirico Inc. announced that they have entered into a strategic multi-target discovery collaboration. Through each company’s proprietary technologies, the multi-target…
Read More...

Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. a special purpose…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for use in adult patients with…
Read More...

Spark Therapeutics, a member of the Roche Group and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced a…
Read More...